Crispr Therapeutics shares tumble after significant earnings miss
LONDON - Two senior executives of The Pebble Group PLC (LSE:PBBL) have reinvested their cash dividends to acquire additional shares in the company, according to a regulatory filing Tuesday.
Chief Executive Officer Christopher Lee purchased 4,368 ordinary shares at 46 pence per share, while Chief Financial Officer Claire Thomson acquired 3,236 shares at the same price. The transactions occurred on June 13 when dividend payments were automatically reinvested through their respective International Share Trust Accounts.
Following these acquisitions, Lee now holds 6,474,442 ordinary shares, representing 4.06% of the company’s issued share capital. Thomson’s holdings increased to 2,990,893 shares, equivalent to 1.88% of the company’s shares.
The Pebble Group, which provides technology, services and products to the global promotional products industry, reported it was notified of these transactions on June 16.
The share purchases were made on the London Stock Exchange (LON:LSEG) through MUFG Corporate Markets, which serves as the International Share Trust Account provider for both executives.
The information was disclosed in accordance with UK Market Abuse Regulation requirements through a regulatory news service filing by the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.